Portfolio
4
companies
PolyAI
PolyAI provides enterprise voice assistants powered by artificial intelligence.
Snyk
Snyk provides developer security tools to help enterprises build software securely.
Papercup
Papercup provides AI video and audio dubbing services featuring expressive synthetic voices.
Quanta Dialysis Technologies
Quanta Dialysis Technologies provides compact dialysis systems for clinical and home use.
Michael Clarke
Managing Partner
Chris Eng
Principal
The company has raised £39.5m from new and existing investors to support its conversational artificial intelligence technology.
"I was extremely impressed with PolyAI’s intuitive and natural conversational abilities and the impact it will have on customer experience"
The financing round included participation from Evolution Equity Partners, G Squared, Irving Investors, boldstart ventures, Sands Capital and Tiger Global.
"In 2022, I’m proud that Snyk achieved a 100% year-over-year increase in revenue as well as net revenue retention of over 130%,"
Octopus Ventures led the Series A round to support machine learning research and language expansion.
"People retain up to 70% more information when watching videos dubbed in their native language. With truly emotive cross-lingual AI dubbing, we can tackle all forms of content, making video and audio more accessible and enjoyable for everyone. This funding will allow us to double down on our promising research and break into new content categories."
The funding round values the developer security platform at £8.5bn.
"This new investment, together with the rapid adoption of our platform and growing customer base, validates our developer security vision,"
The financing round was led by Glenview Capital and co-led by Novo Holdings.
"Everybody knows that dialysis care must improve. For this to happen, providers and physicians need products that allow greater flexibility to bring dialysis directly to the patient, while simplifying complexity and reducing the overall cost of care. Our small, simple-to-use, and powerful dialysis system SC+ is positioned to help transform kidney care. The funding we are announcing today will allow us to accelerate our emergence as a significant force in this market."
